AMEX · LABU
Financial Services · Asset Management
$235.99
Up+$23.20 (+10.90%)
Updated Oct 21, 2026, 7:06 AM
SID Score
4.3/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · LABU
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 20, 2026
LABU closed at $235.99 after 21 trading sessions, down 18.34% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 20, 2026 | $213.22 | $239.38 | $213.22 | $235.99 | 465.71K |
| Oct 19, 2026 | $204.08 | $215.99 | $202.11 | $212.79 | 407.44K |
| Oct 16, 2026 | $224.56 | $224.56 | $196.56 | $198.86 | 478.12K |
| Oct 15, 2026 | $214.17 | $227.57 | $211.575 | $222.94 | 408.69K |
| Oct 14, 2026 | $206.99 | $218.95 | $203.30 | $210.02 | 357.74K |
| Oct 13, 2026 | $229.00 | $229.00 | $210.1596 | $210.78 | 426.64K |
| Oct 12, 2026 | $241.52 | $244.6716 | $230.2215 | $231.99 | 295.57K |
| Oct 9, 2026 | $223.71 | $246.22 | $222.45 | $243.09 | 607.6K |
| Oct 8, 2026 | $221.88 | $224.8479 | $208.28 | $223.00 | 804.93K |
| Oct 7, 2026 | $224.64 | $237.30 | $220.50 | $227.75 | 433.42K |
| Oct 6, 2026 | $260.26 | $260.26 | $224.66 | $230.95 | 999.82K |
| Oct 5, 2026 | $252.91 | $259.09 | $239.49 | $257.38 | 414.35K |
| Oct 2, 2026 | $256.755 | $259.39 | $244.53 | $248.72 | 344.92K |
| Oct 1, 2026 | $261.76 | $271.79 | $248.93 | $249.65 | 444.69K |
| Sep 30, 2026 | $265.34 | $276.21 | $259.25 | $265.79 | 295.12K |
| Sep 29, 2026 | $257.70 | $265.5638 | $249.65 | $261.00 | 332.78K |
| Sep 28, 2026 | $249.49 | $264.4935 | $245.38 | $260.00 | 316.04K |
| Sep 25, 2026 | $261.12 | $262.6105 | $246.005 | $252.47 | 245.36K |
| Sep 24, 2026 | $250.10 | $261.3732 | $240.22 | $257.32 | 435.06K |
| Sep 23, 2026 | $287.90 | $293.10 | $249.08 | $253.11 | 896.31K |
| Sep 22, 2026 | $275.20 | $291.643 | $271.89 | $289.00 | 363.73K |
The latest Smart Investors Daily articles mentioning LABU.
Company
Market Activity
Research & News
LABU research
Company profile and research snapshot.
The fund invests at least 80% of its net assets (plus borrowing for investment purposes) in financial instruments and securities of the index, exchange-traded funds ("ETFs") that track the index and other financial instruments that provide daily leveraged exposure to the index or ETFs that track the index. The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.
Consensus and target data currently published for this company.
No generated briefing is available yet.
defenseworld.net · Dec 7, 2025
Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU - Get Free Report) shares hit a new 52-week high during mid-day trading on Friday. The company traded as high as $169.50 and last traded at $167.9060, with a volume of 88167 shares changing hands. The stock had previously closed at $166.04. Direxion Daily S&P Biotech
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning LABU.
